[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:autosomal-recessive-bestrophinopathy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Autosomal-Recessive Bestrophinopathy",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07185256","Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:46.948970Z","2026-05-05T02:43:26.716969Z",[],[]]